Normal Saline Versus Plasmalyte in Initial Resuscitation of Trauma Patients
NCT ID: NCT01270854
Last Updated: 2017-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2011-02-28
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Aim of This Investigation is to Compare the Influence of 0.9% Saline and Plasmalyte Solution on Acid-base Balance and Electrolytes in Healthy Patients Undergoing Major Spine Surgeries.
NCT01855542
Plasma-Lyte 148® versUs Saline Study
NCT02721654
Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation
NCT00885404
Plasmalyte Versus Saline in Trauma Patients
NCT03630224
Lactated Ringer's and PlasmaLyte in Critically Ill Adults
NCT03813563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Plasmalyte
Administration of Plasmalyte A as the standard intravenous fluid during the first 24 hours after arrival to the hospital
Plasmalyte A
Intravenous fluid
Normal Saline
Administration of Normal Saline as the standard intravenous fluid during the first 24 hours after arrival to the hospital
Normal Saline
Intravenous fluid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Plasmalyte A
Intravenous fluid
Normal Saline
Intravenous fluid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age
* Meets at least one of the following criteria:
1. Intubated or likely to become intubated within 60 minutes of arrival at the hospital
2. Likely to need an operation within 60 minutes of arrival
3. Received or likely to receive a blood transfusion within 60 minutes of arrival
Exclusion Criteria
* Death likely within 48 hours
* Transfer from another hospital
* Pre-existing renal failure requiring dialysis
* Pregnancy
* Prisoner status
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayer
INDUSTRY
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Garth H. Utter, MD
Role: STUDY_DIRECTOR
University of California, Davis
Lynette A. Scherer, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Davis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California, Davis, Medical Center
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Young JB, Utter GH, Schermer CR, Galante JM, Phan HH, Yang Y, Anderson BA, Scherer LA. Saline versus Plasma-Lyte A in initial resuscitation of trauma patients: a randomized trial. Ann Surg. 2014 Feb;259(2):255-62. doi: 10.1097/SLA.0b013e318295feba.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200917793
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.